BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9879431)

  • 1. Monitoring of response to radiotherapy with fluorine-18 deoxyglucose PET of head and neck squamous cell carcinomas.
    Sakamoto H; Nakai Y; Ohashi Y; Matsuda M; Sakashita T; Nasako Y; Kitayama H; Kawabe J; Okamura T; Ochi H
    Acta Otolaryngol Suppl; 1998; 538():254-60. PubMed ID: 9879431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FDG-PET for prediction of tumour aggressiveness and response to intra-arterial chemotherapy and radiotherapy in head and neck cancer.
    Kitagawa Y; Sano K; Nishizawa S; Nakamura M; Ogasawara T; Sadato N; Yonekura Y
    Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):63-71. PubMed ID: 12483411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective comparison of 18F-FDG PET with conventional imaging modalities (MRI, CT, and 67Ga scintigraphy) in assessment of combined intraarterial chemotherapy and radiotherapy for head and neck carcinoma.
    Kitagawa Y; Nishizawa S; Sano K; Ogasawara T; Nakamura M; Sadato N; Yoshida M; Yonekura Y
    J Nucl Med; 2003 Feb; 44(2):198-206. PubMed ID: 12571209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FDG PET to evaluate combined intra-arterial chemotherapy and radiotherapy of head and neck neoplasms.
    Kitagawa Y; Sadato N; Azuma H; Ogasawara T; Yoshida M; Ishii Y; Yonekura Y
    J Nucl Med; 1999 Jul; 40(7):1132-7. PubMed ID: 10405132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of post-radiation therapy FDG PET in prediction of necessity for post-radiation therapy neck dissection in locally advanced head-and-neck squamous cell carcinoma.
    Yao M; Graham MM; Hoffman HT; Smith RB; Funk GF; Graham SM; Dornfeld KJ; Skwarchuk M; Menda Y; Buatti JM
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1001-10. PubMed ID: 15234033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can post-RT neck dissection be omitted for patients with head-and-neck cancer who have a negative PET scan after definitive radiation therapy?
    Rogers JW; Greven KM; McGuirt WF; Keyes JW; Williams DW; Watson NE; Geisinger K; Cappellari JO
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):694-7. PubMed ID: 14967422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of positron emission tomography in occult primary head and neck cancers.
    Safa AA; Tran LM; Rege S; Brown CV; Mandelkern MA; Wang MB; Sadeghi A; Juillard G
    Cancer J Sci Am; 1999; 5(4):214-8. PubMed ID: 10439166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early evaluation of the response to radiotherapy of patients with squamous cell carcinoma of the head and neck using 18FDG-PET.
    Nam SY; Lee SW; Im KC; Kim JS; Kim SY; Choi SH; Ryu JS; Moon DH; Oh SJ; Yi BY; Kim JH; Ahn SD; Shin SS; Kim SB; Choi EK; Lee BJ
    Oral Oncol; 2005 Apr; 41(4):390-5. PubMed ID: 15792611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of recurrent head and neck squamous cell carcinomas after radiation therapy with 2-18F-fluoro-2-deoxy-D-glucose positron emission tomography.
    Farber LA; Benard F; Machtay M; Smith RJ; Weber RS; Weinstein GS; Chalian AA; Alavi A; Rosenthal DI
    Laryngoscope; 1999 Jun; 109(6):970-5. PubMed ID: 10369292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between CT- and FDG-PET-defined target volumes for radiotherapy planning in head-and-neck cancers.
    Henriques de Figueiredo B; Barret O; Demeaux H; Lagarde P; De-Mones-Del-Pujol E; Kantor G; de Clermont-Gallerande H; Richaud P; Fernandez P
    Radiother Oncol; 2009 Dec; 93(3):479-82. PubMed ID: 19880207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Change induced by radiation therapy in FDG uptake in normal and malignant structures of the head and neck: quantitation with PET.
    Rege SD; Chaiken L; Hoh CK; Choi Y; Lufkin R; Anzai Y; Juillard G; Maddahi J; Phelps ME; Hawkins RA
    Radiology; 1993 Dec; 189(3):807-12. PubMed ID: 8234708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of survival with fluorine-18-fluoro-deoxyglucose and PET in head and neck cancer.
    Minn H; Lapela M; Klemi PJ; Grénman R; Leskinen S; Lindholm P; Bergman J; Eronen E; Haaparanta M; Joensuu H
    J Nucl Med; 1997 Dec; 38(12):1907-11. PubMed ID: 9430467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic evaluation of malignant head and neck cancer by F-18-FDG PET compared to CT/MRI.
    Nowak B; Di Martino E; Jänicke S; Cremerius U; Adam G; Zimny M; Reinartz P; Büll U
    Nuklearmedizin; 1999; 38(8):312-8. PubMed ID: 10615664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PET in the assessment of therapy response in patients with carcinoma of the head and neck and of the esophagus.
    Kostakoglu L; Goldsmith SJ
    J Nucl Med; 2004 Jan; 45(1):56-68. PubMed ID: 14734674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detailed characterization of the early response of head-neck cancer xenografts to irradiation using (18)F-FDG-PET imaging.
    Huang J; Chunta JL; Amin M; Lee DY; Grills IS; Wong CY; Yan D; Marples B; Martinez AA; Wilson GD
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):485-91. PubMed ID: 22331000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Feasibility of 18F-FDG PET scans 1 month after completing radiotherapy of squamous cell carcinoma of the head and neck.
    Kim SY; Lee SW; Nam SY; Im KC; Kim JS; Oh SJ; Ahn SD; Shin SS; Choi EK; Kim JH
    J Nucl Med; 2007 Mar; 48(3):373-8. PubMed ID: 17332614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FDG-PET in radiotherapy treatment planning of advanced head and neck cancer--a prospective clinical analysis.
    Dietl B; Marienhagen J; Kühnel T; Schaefer C; Kölbl O
    Auris Nasus Larynx; 2006 Sep; 33(3):303-9. PubMed ID: 16497462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The diagnostic value of positron emission tomography (PET) with radiolabelled fluorodeoxyglucose (18F-FDG) in head and neck cancer.
    Slevin NJ; Collins CD; Hastings DL; Waller ML; Johnson RJ; Cowan RA; Birzgalis AR; Farrington WT; Swindell R
    J Laryngol Otol; 1999 Jun; 113(6):548-54. PubMed ID: 10605586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics and Limitations of FDG PET/CT for Imaging of Squamous Cell Carcinoma of the Head and Neck: A Comprehensive Review of Anatomy, Metastatic Pathways, and Image Findings.
    Plaxton NA; Brandon DC; Corey AS; Harrison CE; Karagulle Kendi AT; Halkar RK; Barron BJ
    AJR Am J Roentgenol; 2015 Nov; 205(5):W519-31. PubMed ID: 26496574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positron emission tomography of patients with head and neck carcinoma before and after high dose irradiation.
    Greven KM; Williams DW; Keyes JW; McGuirt WF; Watson NE; Randall ME; Raben M; Geisinger KR; Cappellari JO
    Cancer; 1994 Aug; 74(4):1355-9. PubMed ID: 8055460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.